QQQ   424.84 (-0.23%)
AAPL   167.31 (-0.41%)
MSFT   408.68 (-0.77%)
META   508.55 (+2.91%)
GOOGL   156.51 (+0.67%)
AMZN   181.37 (+0.05%)
TSLA   149.94 (-3.54%)
NVDA   855.17 (+1.76%)
AMD   155.66 (+1.06%)
NIO   4.00 (+2.30%)
BABA   69.04 (+0.32%)
T   16.17 (+0.31%)
F   12.04 (+0.00%)
MU   112.87 (-2.97%)
GE   155.84 (+0.11%)
CGC   7.89 (+21.57%)
DIS   113.24 (+0.27%)
AMC   2.91 (-2.35%)
PFE   25.27 (-0.59%)
PYPL   62.44 (-1.30%)
XOM   118.52 (-0.09%)
QQQ   424.84 (-0.23%)
AAPL   167.31 (-0.41%)
MSFT   408.68 (-0.77%)
META   508.55 (+2.91%)
GOOGL   156.51 (+0.67%)
AMZN   181.37 (+0.05%)
TSLA   149.94 (-3.54%)
NVDA   855.17 (+1.76%)
AMD   155.66 (+1.06%)
NIO   4.00 (+2.30%)
BABA   69.04 (+0.32%)
T   16.17 (+0.31%)
F   12.04 (+0.00%)
MU   112.87 (-2.97%)
GE   155.84 (+0.11%)
CGC   7.89 (+21.57%)
DIS   113.24 (+0.27%)
AMC   2.91 (-2.35%)
PFE   25.27 (-0.59%)
PYPL   62.44 (-1.30%)
XOM   118.52 (-0.09%)
QQQ   424.84 (-0.23%)
AAPL   167.31 (-0.41%)
MSFT   408.68 (-0.77%)
META   508.55 (+2.91%)
GOOGL   156.51 (+0.67%)
AMZN   181.37 (+0.05%)
TSLA   149.94 (-3.54%)
NVDA   855.17 (+1.76%)
AMD   155.66 (+1.06%)
NIO   4.00 (+2.30%)
BABA   69.04 (+0.32%)
T   16.17 (+0.31%)
F   12.04 (+0.00%)
MU   112.87 (-2.97%)
GE   155.84 (+0.11%)
CGC   7.89 (+21.57%)
DIS   113.24 (+0.27%)
AMC   2.91 (-2.35%)
PFE   25.27 (-0.59%)
PYPL   62.44 (-1.30%)
XOM   118.52 (-0.09%)
QQQ   424.84 (-0.23%)
AAPL   167.31 (-0.41%)
MSFT   408.68 (-0.77%)
META   508.55 (+2.91%)
GOOGL   156.51 (+0.67%)
AMZN   181.37 (+0.05%)
TSLA   149.94 (-3.54%)
NVDA   855.17 (+1.76%)
AMD   155.66 (+1.06%)
NIO   4.00 (+2.30%)
BABA   69.04 (+0.32%)
T   16.17 (+0.31%)
F   12.04 (+0.00%)
MU   112.87 (-2.97%)
GE   155.84 (+0.11%)
CGC   7.89 (+21.57%)
DIS   113.24 (+0.27%)
AMC   2.91 (-2.35%)
PFE   25.27 (-0.59%)
PYPL   62.44 (-1.30%)
XOM   118.52 (-0.09%)
Free Trial

BriaCell Therapeutics (BCTX) Stock Forecast & Price Target

→ [Urgent!] Generational Wealth Gameplan (From Crypto 101 Media) (Ad)
Free BCTX Stock Alerts
$2.21
+0.05 (+2.31%)
(As of 11:33 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

BriaCell Therapeutics Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Buy
Based on 1 Analyst Ratings

Analysts' Consensus Price Target

$18.00
714.48% Upside
High Forecast$18.00
Average Forecast$18.00
Low Forecast$18.00
TypeCurrent Forecast
4/19/23 to 4/18/24		1 Month Ago
3/20/23 to 3/19/24		3 Months Ago
1/19/23 to 1/19/24		1 Year Ago
4/19/22 to 4/19/23
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$18.00$18.00$18.00$25.00
Predicted Upside714.48% Upside227.87% Upside227.87% Upside257.65% Upside
Get BriaCell Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter.

BCTX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BCTX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

BriaCell Therapeutics Stock vs. The Competition

TypeBriaCell TherapeuticsMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.68
2.49
Consensus RatingBuyModerate BuyHold
Predicted Upside714.48% Upside921.86% Upside11.95% Upside
News Sentiment RatingNegative News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/28/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$18.00+227.87%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 01:09 PM ET.

BCTX Price Target - Frequently Asked Questions

What is BriaCell Therapeutics's consensus rating and price target?

According to the issued ratings of 1 analysts in the last year, the consensus rating for BriaCell Therapeutics stock is Buy based on the current 1 buy rating for BCTX. The average twelve-month price prediction for BriaCell Therapeutics is $18.00 with a high price target of $18.00 and a low price target of $18.00. Learn more on BCTX's analyst rating history.

Do Wall Street analysts like BriaCell Therapeutics more than its competitors?

Analysts like BriaCell Therapeutics more than other Medical companies. The consensus rating for BriaCell Therapeutics is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how BCTX compares to other companies.

Does BriaCell Therapeutics's stock price have much upside?

According to analysts, BriaCell Therapeutics's stock has a predicted upside of 227.87% based on their 12-month stock forecasts.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:BCTX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
Biden’s $374B Giveaway Into This Sector
DTI
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Paradigm Press
The “Perfect Storm” for Gold
Gold Safe Exchange
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research